Efficacy of lapachol on treatment of cutaneous and visceral leishmaniasis
- PMID: 30797783
- DOI: 10.1016/j.exppara.2019.02.013
Efficacy of lapachol on treatment of cutaneous and visceral leishmaniasis
Abstract
Leishmaniasis is one of the most important neglected diseases worldwide. It is a life-threatening disease and causes significant morbidity, long-term disability, and early death. Treatment involves disease control or use of intervention measures, although the currently used drugs require long-lasting therapy, and display toxicity and reduced efficacy. The use of natural products isolated from plants, such as lapachol, an abundant naphthoquinone naturally occurring in South American Handroanthus species (Tabebuia, Bignoniaceae), is a promising option for the treatment of leishmaniasis. In this study, we investigated the leishmanicidal activity of lapachol in vitro and in vivo against Leishmania infantum and L. amazonensis, causative agents of visceral and cutaneous leishmaniasis, respectively. Low cytotoxicity in HepG2 cells (3405.8 ± 261.33 μM), good anti-Leishmania activity, and favorable selectivity indexes (SI) against promastigotes of both L. amazonensis (IC50 = 79.84 ± 9.10 μM, SI = 42.65) and L. infantum (IC50 = 135.79 ± 33.04 μM, SI = 25.08) were observed. Furthermore, anti-Leishmania activity assays performed on intracellular amastigotes showed good activity for lapachol (IC50 = 191.95 μM for L. amazonensis and 171.26 μM for L. infantum). Flow cytometric analysis demonstrated that the cytotoxic effect of lapachol in Leishmania promastigotes was caused by apoptosis-like death. Interestingly, the in vitro leishmanicidal effect of lapachol was confirmed in vivo in murine models of visceral and cutaneous leishmaniasis, as lapachol (25 mg/kg oral route for 24 h over 10 days) was able to significantly reduce the parasitic load in skin lesions, liver, and spleen, similar to amphotericin B, the reference drug. These results reinforce the therapeutic potential of lapachol, which warrants further investigations as an anti-leishmaniasis therapeutic.
Keywords: L. amazonensis; Lapachol; Leishmania infantum; Leishmaniasis; Naphthoquinones; Natural products.
Copyright © 2019 Elsevier Inc. All rights reserved.
Similar articles
-
Antileishmanial Activities of Medicinal Herbs and Phytochemicals In Vitro and In Vivo: An Update for the Years 2015 to 2021.Molecules. 2022 Nov 4;27(21):7579. doi: 10.3390/molecules27217579. Molecules. 2022. PMID: 36364404 Free PMC article. Review.
-
Evaluation of the in vitro and in vivo antileishmanial activity of a chloroquinolin derivative against Leishmania species capable of causing tegumentary and visceral leishmaniasis.Exp Parasitol. 2019 Apr;199:30-37. doi: 10.1016/j.exppara.2019.02.019. Epub 2019 Feb 25. Exp Parasitol. 2019. PMID: 30817917
-
In vitro and in vivo antileishmanial activity of a fluoroquinoline derivate against Leishmania infantum and Leishmania amazonensis species.Acta Trop. 2019 Mar;191:29-37. doi: 10.1016/j.actatropica.2018.12.036. Epub 2018 Dec 23. Acta Trop. 2019. PMID: 30586571
-
An effective in vitro and in vivo antileishmanial activity and mechanism of action of 8-hydroxyquinoline against Leishmania species causing visceral and tegumentary leishmaniasis.Vet Parasitol. 2016 Feb 15;217:81-8. doi: 10.1016/j.vetpar.2016.01.002. Epub 2016 Jan 7. Vet Parasitol. 2016. PMID: 26827866
-
Exploring Innovative Leishmaniasis Treatment: Drug Targets from Pre-Clinical to Clinical Findings.Chem Biodivers. 2021 Sep;18(9):e2100336. doi: 10.1002/cbdv.202100336. Epub 2021 Aug 9. Chem Biodivers. 2021. PMID: 34369662 Review.
Cited by
-
Antileishmanial Activities of Medicinal Herbs and Phytochemicals In Vitro and In Vivo: An Update for the Years 2015 to 2021.Molecules. 2022 Nov 4;27(21):7579. doi: 10.3390/molecules27217579. Molecules. 2022. PMID: 36364404 Free PMC article. Review.
-
Crystal structure and Hirshfeld surface analysis of lapachol acetate 80 years after its first synthesis.Acta Crystallogr E Crystallogr Commun. 2019 Aug 19;75(Pt 9):1362-1366. doi: 10.1107/S2056989019011393. eCollection 2019 Sep 1. Acta Crystallogr E Crystallogr Commun. 2019. PMID: 31523467 Free PMC article.
-
In Silico Antiprotozoal Evaluation of 1,4-Naphthoquinone Derivatives against Chagas and Leishmaniasis Diseases Using QSAR, Molecular Docking, and ADME Approaches.Pharmaceuticals (Basel). 2022 May 31;15(6):687. doi: 10.3390/ph15060687. Pharmaceuticals (Basel). 2022. PMID: 35745607 Free PMC article.
-
In vitro and in vivo antileishmanial activity of β-acetyl-digitoxin, a cardenolide of Digitalis lanata potentially useful to treat visceral leishmaniasis.Parasite. 2021;28:38. doi: 10.1051/parasite/2021036. Epub 2021 Apr 14. Parasite. 2021. PMID: 33851916 Free PMC article.
-
Low doses of 3-phenyl-lawsone or meglumine antimoniate delivery by tattooing route are successful in reducing parasite load in cutaneous lesions of Leishmania (Viannia) braziliensis-infected hamsters.Front Cell Infect Microbiol. 2023 Jan 19;13:1025359. doi: 10.3389/fcimb.2023.1025359. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 36743305 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources